Evoke Pharma, Inc. (EVOK)
USD 3.09
(6.19%)
USD 3.09
(6.19%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -27.97 USD | 10.38% |
| 2022 | -31.16 USD | 22.85% |
| 2021 | -40.40 USD | 45.99% |
| 2020 | -74.91 USD | -63.35% |
| 2019 | -45.84 USD | 30.16% |
| 2018 | -65.62 USD | 44.47% |
| 2017 | -118.21 USD | 28.67% |
| 2016 | -165.75 USD | 38.43% |
| 2015 | -269.13 USD | 14.88% |
| 2014 | -316.23 USD | -83.37% |
| 2013 | -172.49 USD | 33.29% |
| 2012 | -234.27 USD | 15.13% |
| 2011 | -304.11 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.93 USD | 55.5% |
| 2024 Q1 | -0.17 USD | 70.69% |
| 2023 FY | - USD | 10.38% |
| 2023 Q3 | -0.51 USD | 8.93% |
| 2023 Q2 | -0.56 USD | 23.29% |
| 2023 Q4 | -0.59 USD | -15.69% |
| 2023 Q1 | -0.73 USD | -37.74% |
| 2022 FY | - USD | 22.85% |
| 2022 Q2 | -0.71 USD | 11.25% |
| 2022 Q1 | -0.80 USD | -29.03% |
| 2022 Q3 | -0.60 USD | 15.49% |
| 2022 Q4 | -0.53 USD | 11.67% |
| 2021 Q3 | -0.73 USD | 14.12% |
| 2021 FY | - USD | 45.99% |
| 2021 Q1 | -1.00 USD | 6.54% |
| 2021 Q2 | -0.85 USD | 15.0% |
| 2021 Q4 | -0.62 USD | 15.07% |
| 2020 Q3 | -0.98 USD | 70.75% |
| 2020 Q2 | -3.35 USD | -280.68% |
| 2020 Q1 | -0.88 USD | -15.79% |
| 2020 FY | - USD | -63.35% |
| 2020 Q4 | -1.07 USD | -9.18% |
| 2019 Q4 | -0.76 USD | 6.17% |
| 2019 Q1 | -1.35 USD | -6.3% |
| 2019 Q2 | -1.09 USD | 19.26% |
| 2019 Q3 | -0.81 USD | 25.69% |
| 2019 FY | - USD | 30.16% |
| 2018 Q4 | -1.27 USD | -19.81% |
| 2018 Q3 | -1.06 USD | 36.9% |
| 2018 FY | - USD | 44.47% |
| 2018 Q1 | -1.54 USD | -541.67% |
| 2018 Q2 | -1.68 USD | -9.09% |
| 2017 FY | - USD | 28.67% |
| 2017 Q4 | -0.24 USD | 94.15% |
| 2017 Q3 | -4.10 USD | -222.83% |
| 2017 Q2 | -1.27 USD | 71.65% |
| 2017 Q1 | -4.48 USD | -200.67% |
| 2016 Q3 | -3.48 USD | 29.55% |
| 2016 FY | - USD | 38.43% |
| 2016 Q2 | -4.94 USD | 8.52% |
| 2016 Q1 | -5.40 USD | -22.17% |
| 2016 Q4 | -1.49 USD | 57.18% |
| 2015 Q4 | -4.42 USD | 12.48% |
| 2015 Q2 | -6.26 USD | 9.54% |
| 2015 Q1 | -6.92 USD | -19.31% |
| 2015 Q3 | -5.05 USD | 19.33% |
| 2015 FY | - USD | 14.88% |
| 2014 Q2 | -7.06 USD | -19.46% |
| 2014 Q3 | -7.58 USD | -7.37% |
| 2014 Q4 | -5.80 USD | 23.48% |
| 2014 FY | - USD | -83.37% |
| 2014 Q1 | -5.91 USD | -2088.89% |
| 2013 Q4 | -0.27 USD | 94.49% |
| 2013 Q1 | -5.23 USD | -771.67% |
| 2013 FY | - USD | 33.29% |
| 2013 Q2 | -2.53 USD | 51.63% |
| 2013 Q3 | -4.90 USD | -93.68% |
| 2012 FY | - USD | 15.13% |
| 2012 Q1 | -5.28 USD | 0.0% |
| 2012 Q2 | -0.32 USD | 93.94% |
| 2012 Q3 | -5.18 USD | -1518.75% |
| 2012 Q4 | -0.60 USD | 88.42% |
| 2011 FY | - USD | 0.0% |